-
EP4079303
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4079303
| EP4079303 - USE OF NAPHTHYLUREA COMPOUND [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.09.2022 Database last updated on 08.10.2024 | |
| Former | The international publication has been made Status updated on 25.06.2021 | Most recent event Tooltip | 09.02.2024 | Amendment by applicant | Applicant(s) | For all designated states Suzhou Raymon Pharmaceuticals Company, Ltd. Unit 502, Building B2, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215123 / CN | [2022/43] | Inventor(s) | 01 /
ZHANG, Fei Unit 502, Building B2, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215123 / CN | 02 /
WANG, Sen Unit 502, Building B2, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215123 / CN | 03 /
ZHANG, Yanhong Unit 502, Building B2, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215123 / CN | [2022/43] | Representative(s) | Greaves Brewster LLP Copa House Station Road Cheddar, Somerset BS27 3AH / GB | [2022/43] | Application number, filing date | 19956312.3 | 16.12.2019 | [2022/43] | WO2019CN125567 | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021119902 | Date: | 24.06.2021 | Language: | ZH | [2021/25] | Type: | A1 Application with search report | No.: | EP4079303 | Date: | 26.10.2022 | Language: | EN | [2022/43] | Search report(s) | International search report - published on: | CN | 24.06.2021 | (Supplementary) European search report - dispatched on: | EP | 21.07.2023 | Classification | IPC: | A61K31/416, A61K31/437, C07D231/56, C07D471/04, A61P27/02 | [2022/43] | CPC: |
A61P27/02 (EP,US);
A61K31/437 (EP,US);
A61K31/416 (EP,US);
A61K9/0048 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/43] | Title | German: | VERWENDUNG EINER NAPHTHYLHARNSTOFFVERBINDUNG | [2022/43] | English: | USE OF NAPHTHYLUREA COMPOUND | [2022/43] | French: | UTILISATION D'UN COMPOSÉ DE NAPHTHYLURÉE | [2022/43] | Entry into regional phase | 22.06.2022 | Translation filed | 12.07.2022 | National basic fee paid | 12.07.2022 | Search fee paid | 12.07.2022 | Designation fee(s) paid | 12.07.2022 | Examination fee paid | Examination procedure | 12.07.2022 | Examination requested [2022/43] | 08.02.2024 | Amendment by applicant (claims and/or description) | 08.02.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 12.07.2022 | Renewal fee patent year 03 | 29.12.2022 | Renewal fee patent year 04 | 28.12.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2014201127 (KALA PHARMACEUTICALS INC [US], et al); | [X]EP3050881 (RADIANT PHARMA & TECH CO LTD [CN]) |